Skip to content

Novel Body Composition Measurements in Association With Outcomes of Breast Reconstruction Reconstruction

Investigation Into the Utility of Novel Body Composition Measurements in Association With Outcomes of Breast Reconstruction

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07546331
Enrollment
40
Registered
2026-04-22
Start date
2026-02-18
Completion date
2028-12-31
Last updated
2026-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Breast Carcinoma

Keywords

Postmastectomy breast reconstruction

Brief summary

This study compares measurements of body composition to outcomes of breast reconstruction.

Detailed description

PRIMARY OBJECTIVES: 1\. Determine feasibility of collecting measurements of body composition. SECONDARY OBJECTIVES: 1. Define the differences in body composition between participants undergoing breast reconstruction who develop complications and those who do not. 2. To determine the implications of different measures of body composition on outcomes of breast reconstruction. 3. Compare utility of body composition measurements versus other anthropometric assessments on assessing risk of complications following breast surgery. OUTLINE: This is a observational study. Participants are assigned to 1 of 2 cohorts and will be follow-up for up to 2 years.

Interventions

PROCEDUREMeasurement of Body Composition

Body composition measurements collected pre and post operatively using a bioelectrical impedance analyzer.

OTHERChart Review

Clinical and surgical data will be collected from the participants medical records.

Sponsors

University of California, San Francisco
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patients must have histologically confirmed breast malignancy or increased risk of developing a breast malignancy. 2. Age ≥ 18 years. 3. Scheduled to undergo mastectomy with immediate breast reconstruction using a permanent implant, tissue expander, or autologous tissue (e.g. Deep Inferior Epigastric Perforator (DIEP) flap, muscle-sparing Transverse Rectus Abdominis Myocutaneous (msTRAM) flap, Profunda Artery Perforator (PAP) flap). 4. Ability to understand a written informed consent document, and the willingness to sign it.

Exclusion criteria

1. Any significant medical condition or laboratory abnormalities, which places the subject at unacceptable risk if he/she were to participate in the study. 2. Pregnant or breastfeeding. 3. Patients assigned male at birth. 4. Non-cisgender women. 5. Patients with implanted electronic medical devices (e.g. pacemaker, defibrillator). 6. Patients with prosthetic limbs.

Design outcomes

Primary

MeasureTime frameDescription
Proportion of Body Composition Measurement Collectionup to 2 yearsThe proportion of enrolled participants with successfully obtained body composition measurements at both preoperative and postoperative timepoints. A success rate of ≥90% will be considered feasible. The proportion of the participants meets feasibility will be reported.

Secondary

MeasureTime frameDescription
Postoperative Variability of Body Compositionup to 2 yearsTo investigate how body fat measurements change after surgery and how consistent these measurements are when repeated.
Pre- to Postoperative Changes in Body Composition and Their Association with BMIup to 2 yearsAssociations between body fat parameters and changes in BMI will be evaluated using correlative analyses.
Association Between Body Composition Parameters and Postoperative Complications Following Breast Reconstructionup to 2 yearsThe association between body composition parameters and postoperative complications following breast reconstruction will be examined. Complications of interest include infection, seroma, hematoma, delayed wound healing, and tissue necrosis.

Countries

United States

Contacts

CONTACTMichael Choi
Michael.Choi@ucsf.edu877-827-3222
PRINCIPAL_INVESTIGATORMerisas Piper, MD

University of California, San Francisco

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 23, 2026